Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.


Persistent hyperparathyroidism is observed in 17% to 50% of patients at 1 year after renal transplantation. In 10% of these patients, hypercalcemia is also present. This condition increases the risk of vascular calcification, correlating with inferior graft function among patients with interstitial calcification in the renal allograft. Hypertension is… (More)
DOI: 10.1016/j.transproceed.2009.06.167